TP53 somatic mutations and LOH profile in colorectal cancer in Romania

被引:0
|
作者
Murarasu, Daniela [1 ]
Puiu, Liliana [1 ,2 ]
Pitica, Ioana Madalina Aldea [1 ]
Mambet, Cristina [2 ]
Mihalcea, Corina Elena [1 ]
Marincas, Augustin Marian [1 ]
Cinca, Sabin [1 ]
Brasoveanu, Lorelei [3 ]
Diaconu, Carmen Cristina [2 ]
机构
[1] Prof Alex Trestioreanu Inst Oncol, Bucharest, Romania
[2] Stefan S Nicolau Inst Virol, Cellular & Mol Dept, 285 MihaiBravu, Bucharest 030304, Romania
[3] Stefan S Nicolau Inst Virol, Ctr Immunol, Bucharest, Romania
来源
ROMANIAN BIOTECHNOLOGICAL LETTERS | 2018年 / 23卷 / 02期
关键词
colorectal cancer; TP53 somatic mutations and LOH profile; nutrigenomics; WILD-TYPE P53; MUTANT P53; TUMOR-SUPPRESSOR; NITRIC-OXIDE; HETEROZYGOSITY; CARCINOGENESIS; MITOCHONDRIA; INFLAMMATION; EXPRESSION; PATTERNS;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Somatic mutations in TP53 tumor suppressor gene represent common events in colorectal cancer, followed frequently by loss of heterozygosity in the course of disease progression. In order to study the profile of these genetic alterations in Romanian oncologic patients TP53 gene sequencing and loss of heterozygosity analysis were performed in 62 tumor samples and 60 paired normal colon tissue samples collected during curative surgical resection. The rate of TP53 somatic mutations (46.8%) was concordant with published data while the type of mutations and their association with tumor sites exhibited a different pattern. The most prevalent mutation type was the nucleotide transition GC>AT (62.1% of total mutations) that occurred exclusively at the CpG dinucleotide sites. Allelic imbalance at TP53 locus was detected in 50% of colorectal tumors. The geographical variation of CRC might be explained by large differences in lifestyle habits and diet across various regions and ethnical groups. However, larger studies are needed to identify and characterize the distinct features of the colorectal cancer mutational profile in respect to geographical location, combined also with nutrigenomics analysis of the particular dietary nutrients specific for the region.
引用
收藏
页码:13530 / 13540
页数:11
相关论文
共 50 条
  • [11] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    [J]. ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [12] Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Smeby, Jorgen
    Sveen, Anita
    Eilertsen, Ina A.
    Danielsen, Stine A.
    Hoff, Andreas M.
    Eide, Peter W.
    Johannessen, Bjarne
    Hektoen, Merete
    Skotheim, Rolf I.
    Guren, Marianne G.
    Nesbakken, Arild
    Lothe, Ragnhild A.
    [J]. ONCOGENESIS, 2019, 8 (6)
  • [13] KRAS, BRAF and TP53 mutations in Romanian colorectal cancer patients
    Murarasu, Daniela
    Puiu, Liliana
    Mihalcea, Corina
    Cinca, Sabin
    Simion, Laurentiu
    [J]. JOURNAL OF BIOTECHNOLOGY, 2016, 231 : S92 - S92
  • [14] Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Jørgen Smeby
    Anita Sveen
    Ina A. Eilertsen
    Stine A. Danielsen
    Andreas M. Hoff
    Peter W. Eide
    Bjarne Johannessen
    Merete Hektoen
    Rolf I. Skotheim
    Marianne G. Guren
    Arild Nesbakken
    Ragnhild A. Lothe
    [J]. Oncogenesis, 8
  • [15] TP53 Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon
    Pietrantonio, Filippo
    Biondani, Pamela
    Perrone, Federica
    Di Bartolomeo, Maria
    Pacifici, Monica
    Milione, Massimo
    Melotti, Flavia
    Maggi, Claudia
    Montennurro, Gabriella
    Bossi, Ilaria
    Mariani, Luigi
    de Braud, Filippo
    [J]. ONCOLOGY, 2014, 86 (5-6) : 289 - 294
  • [16] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    [J]. HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [17] TP53 mutation in colorectal cancer
    Iacopetta, B
    [J]. HUMAN MUTATION, 2003, 21 (03) : 271 - 276
  • [18] Germline TP53 codon 72 is associated with somatic mutations in bladder cancer
    Kawahara, Takashi
    Kojima, Takahiro
    Kandori, Shuya
    Kimura, Tomokazu
    Kawai, Koji
    Nishiyama, Hiroyuki
    [J]. CANCER SCIENCE, 2018, 109 : 967 - 967
  • [19] Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer
    Nixon, Mellissa J.
    Estrada, V. Monica
    Opalenki, Susan R.
    Hicks, Donna
    Korrer, Michael
    Sanders, Melinda E.
    Salgado, Roberto
    Kim, Young
    Cook, Rebecca
    Arteaga, Carlos L.
    Balko, Justin M.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [20] PIK3CA and TP53 gene mutations in patients with metastatic colorectal cancer from Northeast Romania
    Afrasanie, V.
    Stratulat, T. Alexa
    Marinca, M.
    Gafton, B.
    Froicu, E.
    Morar, L.
    Lefter, A.
    Rusu, C.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S355 - S355